sglt2 inhibitor glp 1 agonist combination Diabetic Agents, From Metformin to Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar Frontiers | Effects of SGLT2
Description
Further studies investigating the safety of these agents as it relates to the management surrounding the peri-anesthetic period are needed
SAMAS: Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
Preliminary findings suggest that these drugs may have even more unexpected off-label uses, such as helping to reduce alcohol use disorder (AUD) , reduce high blood pressure (hypertension) , and provide defense against heart disease and even dementia
It isn't approved for weight management, but people who take it do lose weight
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
These effects occurred in 4070% of treated patients in clinical trials
